QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
(Address of principal executive offices) |
(Zip Code) | |
☒ |
Accelerated filer |
☐ | ||||
Non-accelerated filer |
☐ |
Smaller reporting company |
||||
Emerging growth company |
||||||
Title of Each Class |
Trading Symbol |
Name of each exchange on which registered | ||
TABLE OF CONTENTS
| Page | ||||||
| PART I—FINANCIAL INFORMATION |
||||||
| Financial Statements | 3 | |||||
| Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 (Unaudited) |
3 | |||||
| 4 | ||||||
| 5 | ||||||
| 6 | ||||||
| 7 | ||||||
| Notes to Condensed Consolidated Financial Statements (Unaudited) |
8 | |||||
| Management’s Discussion and Analysis of Financial Condition and Results of Operations | 92 | |||||
| Quantitative and Qualitative Disclosures About Market Risk | 140 | |||||
| Controls and Procedures | 141 | |||||
| PART II—OTHER INFORMATION |
| |||||
| Legal Proceedings | 142 | |||||
| Risk Factors | 142 | |||||
| Unregistered Sales of Equity Securities and Use of Proceeds | 142 | |||||
| Exhibits | 143 | |||||
| 144 | ||||||
2
March 31, 2023 |
December 31, 2022 |
|||||||
(As adjusted) |
||||||||
Assets |
||||||||
Investments: |
||||||||
Fixed maturity securities available-for-sale, |
$ | $ | ||||||
Equity securities, at fair value |
||||||||
Commercial mortgage loans (net of unamortized balance of loan origination fees and costs of $ |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
Commercial mortgage loans, net |
||||||||
Policy loans |
||||||||
Limited partnerships |
||||||||
Other invested assets |
||||||||
Total investments |
||||||||
Cash, cash equivalents and restricted cash |
||||||||
Accrued investment income |
||||||||
Deferred acquisition costs |
||||||||
Intangible assets |
||||||||
Reinsurance recoverable |
||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ||||
Reinsurance recoverable, net |
||||||||
Other assets |
||||||||
Deferred tax asset |
||||||||
Market risk benefit assets |
||||||||
Separate account assets |
||||||||
Total assets |
$ | $ | ||||||
Liabilities and equity |
||||||||
Liabilities: |
||||||||
Future policy benefits |
$ | $ | ||||||
Policyholder account balances |
||||||||
Market risk benefit liabilities |
||||||||
Liability for policy and contract claims |
||||||||
Unearned premiums |
||||||||
Other liabilities |
||||||||
Long-term borrowings |
||||||||
Separate account liabilities |
||||||||
Liabilities related to discontinued operations |
||||||||
Total liabilities |
||||||||
Commitments and contingencies |
||||||||
Equity: |
||||||||
Class A common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated other comprehensive income (loss) |
( |
) | ( |
) | ||||
Retained earnings |
||||||||
Treasury stock, at cost ( |
( |
) | ( |
) | ||||
Total Genworth Financial, Inc.’s stockholders’ equity |
||||||||
Noncontrolling interests |
||||||||
Total equity |
||||||||
Total liabilities and equity |
$ | $ | ||||||
Three months ended March 31, |
||||||||
2023 |
2022 |
|||||||
(As adjusted) |
||||||||
Revenues: |
||||||||
Premiums |
$ | $ | ||||||
Net investment income |
||||||||
Net investment gains (losses) |
( |
) | ||||||
Policy fees and other income |
||||||||
Total revenues |
||||||||
Benefits and expenses: |
||||||||
Benefits and other changes in policy reserves |
||||||||
Liability remeasurement (gains) losses |
( |
) | ||||||
Changes in fair value of market risk benefits and associated hedges |
( |
) | ||||||
Interest credited |
||||||||
Acquisition and operating expenses, net of deferrals |
||||||||
Amortization of deferred acquisition costs and intangibles |
||||||||
Interest expense |
||||||||
Total benefits and expenses |
||||||||
Income from continuing operations before income taxes |
||||||||
Provision for income taxes |
||||||||
Income from continuing operations |
||||||||
Loss from discontinued operations, net of taxes |
( |
) | ||||||
Net income |
||||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Less: net income from discontinued operations attributable to noncontrolling interests |
||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Net income available to Genworth Financial, Inc.’s common stockholders: |
||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
( |
) | ||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | $ | ||||||
Diluted |
$ | $ | ||||||
Net income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||
Basic |
$ | $ | ||||||
Diluted |
$ | $ | ||||||
Weighted-average common shares outstanding: |
||||||||
Basic |
||||||||
Diluted |
||||||||
Three months ended March 31, |
||||||||
2023 |
2022 |
|||||||
(As adjusted) |
||||||||
Net income |
$ | $ | ||||||
Other comprehensive income (loss), net of taxes: |
||||||||
Net unrealized gains (losses) on securities without an allowance for credit losses |
( |
) | ||||||
Net unrealized gains (losses) on securities with an allowance for credit losses |
( |
) | ||||||
Derivatives qualifying as hedges |
( |
) | ||||||
Change in the discount rate used to measure future policy benefits |
( |
) | ||||||
Change in instrument-specific credit risk of market risk benefits |
||||||||
Foreign currency translation and other adjustments |
( |
) | ||||||
Total other comprehensive income (loss) |
( |
) | ||||||
Total comprehensive income (loss) |
( |
) | ||||||
Less: comprehensive income (loss) attributable to noncontrolling interests |
( |
) | ||||||
Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders |
$ | ( |
) | $ | ||||
Three months ended March 31, 2023 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of December 31, 2022 (as adjusted) |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
||||||||||||||||||||
Repurchase of subsidiary shares |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of taxes |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Total comprehensive income (loss) |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Treasury stock acquired in connection with share repurchases |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Dividends to noncontrolling interests |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Balances as of March 31, 2023 |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
||||||||||||||||||||
Three months ended March 31, 2022 |
||||||||||||||||||||||||||||||||
Common stock |
Additional paid-in capital |
Accumulated other comprehensive income (loss) |
Retained earnings |
Treasury stock, at cost |
Total Genworth Financial, Inc.’s stockholders’ equity |
Noncontrolling interests |
Total equity |
|||||||||||||||||||||||||
Balances as of December 31, 2021 (as adjusted) |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
||||||||||||||||||||
Comprehensive income (loss): |
||||||||||||||||||||||||||||||||
Net income |
||||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of taxes |
( |
) |
||||||||||||||||||||||||||||||
Total comprehensive income (loss) |
( |
) |
||||||||||||||||||||||||||||||
Stock-based compensation expense and exercises and other |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
Balances as of March 31, 2022 (as adjusted) |
$ |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
$ |
||||||||||||||||||||
Three months ended March 31, |
||||||||
2023 |
2022 |
|||||||
(As adjusted) |
||||||||
| Cash flows from (used by) operating activities: |
||||||||
| Net income |
$ | $ | ||||||
| Less loss from discontinued operations, net of taxes |
||||||||
| Adjustments to reconcile net income to net cash from (used by) operating activities: |
||||||||
| Amortization of fixed maturity securities discounts and premiums |
( |
) | ( |
) | ||||
| Net investment (gains) losses |
( |
) | ||||||
| Changes in fair value of market risk benefits and associated hedges |
( |
) | ||||||
| Charges assessed to policyholders |
( |
) | ( |
) | ||||
| Acquisition costs deferred |
( |
) | ( |
) | ||||
| Amortization of deferred acquisition costs and intangibles |
||||||||
| Deferred income taxes |
||||||||
| Derivative instruments, limited partnerships and other |
( |
) | ( |
) | ||||
| Stock-based compensation expense |
||||||||
| Change in certain assets and liabilities: |
||||||||
| Accrued investment income and other assets |
( |
) | ( |
) | ||||
| Insurance reserves |
||||||||
| Current tax liabilities |
||||||||
| Other liabilities, policy and contract claims and other policy-related balances |
( |
) | ( |
) | ||||
| Cash used by operating activities—discontinued operations |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Net cash from (used by) operating activities |
( |
) | ||||||
| |
|
|
|
|||||
| Cash flows from (used by) investing activities: |
||||||||
| Proceeds from maturities and repayments of investments: |
||||||||
| Fixed maturity securities |
||||||||
| Commercial mortgage loans |
||||||||
| Limited partnerships and other invested assets |
||||||||
| Proceeds from sales of investments: |
||||||||
| Fixed maturity and equity securities |
||||||||
| Purchases and originations of investments: |
||||||||
| Fixed maturity and equity securities |
( |
) | ( |
) | ||||
| Commercial mortgage loans |
( |
) | ( |
) | ||||
| Limited partnerships and other invested assets |
( |
) | ( |
) | ||||
| Short-term investments, net |
( |
) | ||||||
| Policy loans, net |
||||||||
| |
|
|
|
|||||
| Net cash from investing activities |
||||||||
| |
|
|
|
|||||
| Cash flows from (used by) financing activities: |
||||||||
| Deposits to universal life and investment contracts |
||||||||
| Withdrawals from universal life and investment contracts |
( |
) | ( |
) | ||||
| Repayment and repurchase of long-term debt |
( |
) | ( |
) | ||||
| Repurchase of subsidiary shares |
( |
) | ||||||
| Treasury stock acquired in connection with share repurchases |
( |
) | ||||||
| Dividends paid to noncontrolling interests |
( |
) | ||||||
| Other, net |
||||||||
| |
|
|
|
|||||
| Net cash used by financing activities |
( |
) | ( |
) | ||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
||||||||
| |
|
|
|
|||||
| Net change in cash, cash equivalents and restricted cash |
( |
) | ( |
) | ||||
| Cash, cash equivalents and restricted cash at beginning of period |
||||||||
| |
|
|
|
|||||
| Cash, cash equivalents and restricted cash at end of period |
||||||||
| Less cash, cash equivalents and restricted cash of discontinued operations at end of period |
||||||||
| |
|
|
|
|||||
| Cash, cash equivalents and restricted cash of continuing operations at end of period |
$ | $ | ||||||
| |
|
|
|
|||||
• |
Enact. |
• |
Long-Term Care Insurance |
• |
Life and Annuities. |
Key Area Impacted |
Change to Accounting Policy |
Policy Elections and Other Significant Matters | ||
DAC and balances amortized on a basis consistent with DAC, including intangible assets and cost of reinsurance |
DAC associated with long-duration insurance contracts is grouped into cohorts consistent with groupings used to estimate the related liability for future policy benefits and is amortized on a constant level basis over the expected contract term, which approximates straight-line. Assumptions used to amortize DAC are consistent with the assumptions used to estimate the liability for future policy benefits. Revised assumptions are recognized prospectively over the remaining term of the related contract. DAC and balances amortized on a basis consistent with DAC are no longer subject to impairment, shadow adjustments or recoverability testing; however, present value of future profits (“PVFP”) is still assessed for recoverability in connection with premium deficiency testing. |
The constant level basis we use to amortize DAC by product is as follows: • long-term care insurance—total life count • life insurance—face amount • fixed and variable annuities—policy count We apply the amortization rate at the beginning of the current reporting period, which reflects assumption updates, if applicable, and actual experience through the end of the current reporting period. We have elected to amortize intangible assets associated with investment contracts, such as PVFP, in a manner consistent with DAC. Cost of reinsurance is deferred and amortized in a manner consistent with DAC over the terms of the related reinsurance treaties. |
Key Area Impacted |
Change to Accounting Policy |
Policy Elections and Other Significant Matters | ||
MRBs, which include contracts or contract features that protect the policyholder’s account balance and expose the insurer to other-than-nominal capital market risk, such as guaranteed minimum death benefits (“GMDBs”), guaranteed minimum withdrawal benefits (“GMWBs”) and guaranteed payout annuity floor benefits (“GPAFs”) |
MRBs are measured at fair value with changes related to instrument-specific credit risk recorded as a separate component in accumulated other comprehensive income (loss) and remaining changes recorded in net income (loss). |
For additional details, see notes 7 and 13. | ||
Liability for future policy benefits—level of aggregation |
For the purpose of calculating the net premium ratio used to measure the liability for future policy benefits, long-duration insurance contracts are grouped into annual cohorts on the basis of original contract issue date. For acquired contracts, the acquisition date is considered the original contract issue date. The net premium ratio for long-duration traditional and limited payment contracts is the ratio of expected benefits less the existing carrying value of reserves to gross premiums. |
Traditional and limited-payment long-duration insurance contracts are generally grouped into annual calendar-year cohorts based on the contract issue date, product type and company. Limited-payment contracts are grouped into cohorts separately from other traditional products and riders are combined with the associated base policies. Certain products may also be grouped by acquisition date for acquired contracts and reinsurance treaty effective date for reinsurance recoverables. | ||
Key Area Impacted |
Change to Accounting Policy |
Policy Elections and Other Significant Matters | ||
| Liability for future policy benefits—cash flow assumptions | All cash flow assumptions used to estimate the liability for future policy benefits (including health care experience, policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity) and insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates)) are reviewed at least annually in the same period each year or more frequently if actual experience indicates a change is required. Changes in cash flow assumptions are recorded using a retrospective approach with a cumulative catch-up adjustment by recalculating the net premium ratio (which is capped at 100%) using actual historical and updated future cash flow assumptions. The liability for future policy benefits is recalculated using the revised net premium ratio and locked-in discount rate as of the beginning of the current reporting period and compared to the carrying amount as of the beginning of the current reporting period using the previous net premium ratio and locked-in discount rate, with any difference recorded as a remeasurement gain (loss). Cash flow assumptions no longer reflect a provision for adverse deviation, and the premium deficiency test and shadow adjustments are eliminated. |
We calculate a single liability for future policy benefits and therefore, all cash flows, including benefit payments (such as claims in course of settlement and incurred claims) are aggregated. As a result, our U.S. life insurance companies elected to combine their previously disclosed liability for policy and contract claims, excluding amounts related to certain life and annuity products not subject to the new accounting guidance, within the liability for future policy benefits and present the aggregate liability as one line item in our condensed consolidated balance sheets. Cash flow assumptions will be formally reviewed and updated as necessary based on experience studies in the fourth quarter each year. We elected to update the net premium ratio quarterly for actual versus expected experience; therefore, during interim reporting periods we will replace forecasted cash flow assumptions with actual cash flows with any difference recorded in net income (loss). We made an entity-wide election not to update our expense assumptions and therefore, these assumptions remain locked-in at the time of the Transition Date or if issued after the Transition Date, at the time of contract inception. |
Key Area Impacted |
Change to Accounting Policy |
Policy Elections and Other Significant Matters | ||
| Liability for future policy benefits—discount rate assumptions | The liability for future policy benefits is measured using two different discount rates, a current discount rate and a locked-in discount rate. The current discount rate is used to remeasure the liability for future policy benefits recorded in the condensed consolidated balance sheets and is a current upper-medium grade fixed-income instrument yield, commonly interpreted to be a single-A rated bond rate, with the same duration as the corresponding liability. The locked-in discount rate is used to determine the amounts recorded to net income (loss) and is held constant for the purpose of calculating the net premium ratio and interest accretion. The difference between the liability measured using the locked-in rate and the liability measured using the current rate is recorded in accumulated other comprehensive income (loss). For policies in-force prior to the Transition Date, the locked-in discount rate is equal to the discount rate in effect immediately before the Transition Date. For contracts issued on or after the Transition Date, the locked-in discount rate is a single-A rated bond rate identified at inception of the contract. |
The methodology used to determine the current discount rate assumption maximizes the use of relevant observable inputs and minimizes the use of unobservable inputs. The current discount rate assumption is based on a single-A curve published by a market data service. For cash flows projected beyond the observable curve, we use estimation techniques consistent with Level 3 fair value measurements as defined in note 2—Summary of Significant Accounting Policies included in the Notes to Consolidated Financial Statements in our 2022 Annual Report on Form 10-K to interpolate from the last observable rate to an estimated ultimate long-term rate. For contracts issued on or after the Transition Date, the locked-in discount rate for each issue-year cohort is determined as a single discount rate, using the weighted-average monthly single-A fixed-income forward curves over the current calendar year. |
Key Area Impacted |
Change to Accounting Policy |
Policy Elections and Other Significant Matters | ||
Liability for future policy benefits—deferred profit liability |
A deferred profit liability is established for limited-payment products at the time of contract issuance for any amount of gross premiums received in excess of net premiums, which is amortized into net income (loss) in proportion to insurance in-force for life insurance products and expected future benefit payments for fixed annuity products. Cash flow assumptions related to the deferred profit liability are consistent with the assumptions used to estimate the related liability for future policy benefits and are updated at the same time. The deferred profit liability is recalculated using updated cash flow assumptions as of the beginning of the current reporting period and compared to the current carrying amount as of the beginning of the current reporting period, with any difference recorded in net income (loss). |
Key Area Impacted |
Change to Accounting Policy |
Policy Elections and Other Significant Matters | ||
Policyholder account balances—additional insurance liabilities |
Additional insurance liabilities are established for guarantees or certain product features not classified as MRBs or embedded derivatives. The calculation of additional insurance liabilities includes investment performance. Therefore, the impacts from net unrealized investment gains and losses on available for-sale investment securities backing additional insurance liabilities are required to be analyzed, as if those unrealized investment gains and losses were realized. These “shadow adjustments” result in the recognition of unrealized gains and losses on additional insurance liabilities in a manner consistent with unrealized gains and losses on available-for-sale investment securities, which are recorded in accumulated other comprehensive income (loss). |
Annual premium deficiency testing is still required to be performed for our universal and term universal life insurance products. |
Effect of adopting LDTI |
||||||||||||||||||||||||
(Amounts in millions) |
As originally reported |
Eliminate shadow adjustments |
Changes in measurement of assets and liabilities |
Change in discount rate |
Recognize MRBs |
As adjusted |
||||||||||||||||||
Assets |
||||||||||||||||||||||||
Total investments |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Cash, cash equivalents and restricted cash |
||||||||||||||||||||||||
Accrued investment income |
||||||||||||||||||||||||
Deferred acquisition costs |
( |
) | ||||||||||||||||||||||
Intangible assets |
( |
) | ( |
) | ||||||||||||||||||||
Reinsurance recoverable |
( |
) | ||||||||||||||||||||||
Less: Allowance for credit losses |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Reinsurance recoverable, net |
( |
) | ||||||||||||||||||||||
Other assets |
( |
) | ||||||||||||||||||||||
Deferred tax asset |
( |
) | ||||||||||||||||||||||
Market risk benefit assets |
||||||||||||||||||||||||
Separate account assets |
||||||||||||||||||||||||
Total assets |
$ | $ | ( |
) | $ | $ | $ | $ | ||||||||||||||||
Liabilities and equity |
||||||||||||||||||||||||
Liabilities: |
||||||||||||||||||||||||
Future policy benefits |
$ | $ | ( |
) | $ | $ | $ | $ | ||||||||||||||||
Policyholder account balances |
( |
) | ( |
) | ||||||||||||||||||||
Market risk benefit liabilities |
||||||||||||||||||||||||
Liability for policy and contract claims |
( |
) | ||||||||||||||||||||||
Unearned premiums |
( |
) | ||||||||||||||||||||||
Other liabilities |
||||||||||||||||||||||||
Long-term borrowings |
||||||||||||||||||||||||
Separate account liabilities |
||||||||||||||||||||||||
Liabilities related to discontinued operations |
||||||||||||||||||||||||
Total liabilities |
( |
) | ||||||||||||||||||||||
Commitments and contingencies |
||||||||||||||||||||||||
Equity: |
||||||||||||||||||||||||
Class A common stock |
||||||||||||||||||||||||
Additional paid-in capital |
||||||||||||||||||||||||
Accumulated other comprehensive income (loss) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Retained earnings |
( |
) | ( |
) | ||||||||||||||||||||
Treasury stock, at cost |
( |
) | ( |
) | ||||||||||||||||||||
Total Genworth Financial, Inc.’s stockholders’ equity |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Noncontrolling interests |
||||||||||||||||||||||||
Total equity |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Total liabilities and equity |
$ | $ | ( |
) | $ | $ | $ | $ | ||||||||||||||||
Effect of adopting LDTI |
||||||||||||||||||||||||
| (Amounts in millions) |
As originally reported |
Change in amortization |
Changes in measurement of insurance liabilities |
Remeasurement (gains) losses |
Change in MRBs |
As adjusted |
||||||||||||||||||
| Revenues: |
||||||||||||||||||||||||
| Premiums |
$ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||
| Net investment income |
||||||||||||||||||||||||
| Net investment gains (losses) |
||||||||||||||||||||||||
| Policy fees and other income |
( |
) | ||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total revenues |
( |
) | ( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Benefits and expenses: |
||||||||||||||||||||||||
| Benefits and other changes in policy reserves |
( |
) | ( |
) | ||||||||||||||||||||
| Liability remeasurement (gains) losses |
( |
) | ( |
) | ||||||||||||||||||||
| Changes in fair value of market risk benefits and associated hedges |
( |
) | ( |
) | ||||||||||||||||||||
| Interest credited |
||||||||||||||||||||||||
| Acquisition and operating expenses, net of deferrals |
||||||||||||||||||||||||
| Amortization of deferred acquisition costs and intangibles |
( |
) | ||||||||||||||||||||||
| Interest expense |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total benefits and expenses |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income from continuing operations before income taxes |
( |
) | ||||||||||||||||||||||
| Provision for income taxes |
( |
) | ||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income from continuing operations |
( |
) | ||||||||||||||||||||||
| Loss from discontinued operations, net of taxes |
( |
) | ( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income |
( |
) | ||||||||||||||||||||||
| Less: net income from continuing operations attributable to noncontrolling interests |
||||||||||||||||||||||||
| Less: net income from discontinued operations attributable to noncontrolling interests |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income (loss) available to Genworth Financial, Inc.’s common stockholders: |
||||||||||||||||||||||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||
| Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
( |
) | ( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | $ | ( |
) | $ | $ | $ | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||||||||||
| Basic |
$ | $ | ||||||||||||||||||||||
| |
|
|
|
|||||||||||||||||||||
| Diluted |
$ | $ | ||||||||||||||||||||||
| |
|
|
|
|||||||||||||||||||||
| Net income available to Genworth Financial, Inc.’s common stockholders per share: |
||||||||||||||||||||||||
| Basic |
$ | $ | ||||||||||||||||||||||
| |
|
|
|
|||||||||||||||||||||
| Diluted |
$ | $ | ||||||||||||||||||||||
| |
|
|
|
|||||||||||||||||||||
| Weighted-average common shares outstanding: |
||||||||||||||||||||||||
| Basic |
||||||||||||||||||||||||
| |
|
|
|
|||||||||||||||||||||
| Diluted |
||||||||||||||||||||||||
| |
|
|
|
|||||||||||||||||||||
Effect of adopting LDTI |
||||||||||||||||||||||||
| (Amounts in millions) |
As originally reported |
Change in amortization |
Changes in measurement of insurance liabilities |
Remeasurement (gains) losses |
Change in MRBs |
As adjusted |
||||||||||||||||||
| Cash flows from (used by) operating activities: |
||||||||||||||||||||||||
| Net income |
$ |
$ |
$ |
( |
) |
$ |
$ |
$ |
||||||||||||||||
| Less loss from discontinued operations, net of taxes |
||||||||||||||||||||||||
| Adjustments to reconcile net income to net cash used by operating activities: |
||||||||||||||||||||||||
| Amortization of fixed maturity securities discounts and premiums |
( |
) |
( |
) | ||||||||||||||||||||
| Net investment (gains) losses |
( |
) |
( |
) |
( |
) | ||||||||||||||||||
| Changes in fair value of market risk benefits and associated hedges |
( |
) |
( |
) | ||||||||||||||||||||
| Charges assessed to policyholders |
( |
) |
( |
) | ||||||||||||||||||||
| Acquisition costs deferred |
( |
) |
( |
) |
( |
) | ||||||||||||||||||
| Amortization of deferred acquisition costs and intangibles |
( |
) |
||||||||||||||||||||||
| Deferred income taxes |
( |
) |
||||||||||||||||||||||
| Derivative instruments, limited partnerships and other |
( |
) |
( |
) | ||||||||||||||||||||
| Stock-based compensation expense |
||||||||||||||||||||||||
| Change in certain assets and liabilities: |
||||||||||||||||||||||||
| Accrued investment income and other assets |
( |
) |
( |
) |
( |
) | ||||||||||||||||||
| Insurance reserves |
( |
) |
( |
) |
||||||||||||||||||||
| Other liabilities, policy and contract claims and other policy-related balances |
( |
) |
( |
) |
( |
) | ||||||||||||||||||
| Cash used by operating activities—discontinued operations |
( |
) |
( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Net cash used by operating activities |
$ |
( |
) |
$ |
$ |
$ |
$ |
$ |
( |
) | ||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Effect of adopting LDTI |
||||||||||||||||||||||||
| (Amounts in millions) |
Balances as of December 31, 2020 (as reported) |
Eliminate shadow adjustments |
Changes in measurement of assets and liabilities |
Change in discount rate |
Recognize MRBs |
Balances as of January 1, 2021 (as adjusted) |
||||||||||||||||||
| Assets |
||||||||||||||||||||||||
| Total investments |
$ |
$ |
$ |
$ |
$ |
$ |
||||||||||||||||||
| Cash, cash equivalents and restricted cash |
||||||||||||||||||||||||
| Accrued investment income |
||||||||||||||||||||||||
| Deferred acquisition costs |
||||||||||||||||||||||||
| Intangible assets |
||||||||||||||||||||||||
| Reinsurance recoverable |
( |
) |
||||||||||||||||||||||
| Less: Allowance for credit losses |
( |
) |
( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Reinsurance recoverable, net |
( |
) |
||||||||||||||||||||||
| Other assets |
( |
) |
||||||||||||||||||||||
| Deferred tax asset |
( |
) |
||||||||||||||||||||||
| Market risk benefit assets |
||||||||||||||||||||||||
| Separate account assets |
||||||||||||||||||||||||
| Assets related to discontinued operations |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total assets |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Liabilities and equity |
||||||||||||||||||||||||
| Liabilities: |
||||||||||||||||||||||||
| Future policy benefits |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
||||||||||||||||
| Policyholder account balances |
( |
) |
( |
) |
||||||||||||||||||||
| Market risk benefit liabilities |
||||||||||||||||||||||||
| Liability for policy and contract claims |
( |
) |
||||||||||||||||||||||
| Unearned premiums |
( |
) |
||||||||||||||||||||||
| Other liabilities |
||||||||||||||||||||||||
| Long-term borrowings |
||||||||||||||||||||||||
| Separate account liabilities |
||||||||||||||||||||||||
| Liabilities related to discontinued operations |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total liabilities |
( |
) |
||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Commitments and contingencies |
||||||||||||||||||||||||
| Equity: |
||||||||||||||||||||||||
| Class A common stock |
||||||||||||||||||||||||
| Additional paid-in capital |
||||||||||||||||||||||||
| Accumulated other comprehensive income (loss) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||
| Retained earnings |
( |
) |
( |
) |
( |
) | ||||||||||||||||||
| Treasury stock, at cost |
( |
) |
( |
) | ||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total Genworth Financial, Inc.’s stockholders’ equity |
( |
) |
( |
) |
( |
) |
||||||||||||||||||
| Noncontrolling interests |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total equity |
( |
) |
( |
) |
( |
) |
||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total liabilities and equity |
$ |
$ |
( |
) |
$ |
$ |
$ |
$ |
||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
(Amounts in millions) |
Accumulated other comprehensive income (loss) |
Retained earnings |
Total stockholders’ equity |
|||||||||
Deferred acquisition costs |
$ | $ | $ | |||||||||
Intangible assets |
||||||||||||
Reinsurance recoverable |
||||||||||||
Other assets |
||||||||||||
Future policy benefits |
( |
) | ( |
) | ( |
) | ||||||
Policyholder account balances |
||||||||||||
Market risk benefits, net |
( |
) | ( |
) | ( |
) | ||||||
Other liabilities |
( |
) | ( |
) | ||||||||
Deferred taxes |
||||||||||||
Total |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
(Amounts in millions) |
Long-term care insurance |
Life insurance |
Fixed annuities |
Variable annuities |
Total |
|||||||||||||||
Balances as of December 31, 2020 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
Adjustment for removal of related balances in accumulated other comprehensive income (loss) |
||||||||||||||||||||
Adjusted balances as of January 1, 2021 |
$ |
$ |
$ |
$ |
||||||||||||||||
Enact segment |
||||||||||||||||||||
Total deferred acquisition costs as of January 1, 2021 |
$ |
|||||||||||||||||||
(Amounts in millions) |
Life insurance |
Fixed annuities |
Variable annuities |
Total |
||||||||||||
Balances as of December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||
Adjustment for removal of related balance in accumulated other comprehensive income (loss) |
||||||||||||||||
Adjusted balances as of January 1, 2021 |
$ |
$ |
$ |
$ |
||||||||||||
(Amounts in millions) |
Long-term care insurance |
Life insurance |
Fixed annuities |
Total |
||||||||||||
Balances as of December 31, 2020 |
$ |
$ |
$ |
$ |
||||||||||||
Reclassify liability for policy and contract claims, unearned premiums and due premiums (1) |
||||||||||||||||
Change in discount rate assumptions |
||||||||||||||||
Change in cash flow assumptions (2) |
( |
) |
||||||||||||||
Change in cash flow assumptions, effect of increase (decrease) of the deferred profit liability (2) |
( |
) |
( |
) | ||||||||||||
Adjustment for removal of related balances in accumulated other comprehensive income (loss) |
( |
) |
( |
) |
( |
) | ||||||||||
Adjusted balances as of January 1, 2021 |
||||||||||||||||
Less: reinsurance recoverable |
||||||||||||||||
Adjusted balances as of January 1, 2021, net of reinsurance |
$ |
$ |
$ |
$ |
||||||||||||
(1) |
Upon adopting LDTI, we elected to combine our previously disclosed liability for policy and contract claims, unearned premiums and due premiums, excluding amounts related to mortgage insurance and certain life and annuity products not subject to the new accounting guidance, within the liability for future policy benefits and present the aggregate liability as one line item in our condensed consolidated balance sheets. |
(2) |
For limited-payment contracts, if the remeasured liability for future policy benefits under LDTI is (less) greater than the carrying value immediately before the Transition Date, the deferred profit liability is increased (decreased) with a corresponding (decrease) increase to the liability for future policy benefits. |
(Amounts in millions) |
Fixed index annuities |
Variable annuities |
Total |
|||||||||
Balances as of December 31, 2020 |
$ | $ | $ | |||||||||
Adjustment for the difference between carrying amount and fair value, except for the difference due to instrument-specific credit risk |
||||||||||||
Adjustment for the cumulative effect of changes in the instrument-specific credit risk since issuance |
||||||||||||
Total adjustment for the difference between carrying amount and fair value |
||||||||||||
Adjusted balances as of January 1, 2021 |
||||||||||||
Less: reinsurance recoverable |
||||||||||||
Adjusted balances as of January 1, 2021, net of reinsurance |
$ | $ | $ | |||||||||
Three months ended March 31, |
||||||||
(Amounts in millions, except per share amounts) |
2023 |
2022 |
||||||
Weighted-average common shares used in basic earnings per share calculations |
||||||||
Potentially dilutive securities: |
||||||||
Stock options, restricted stock units and other equity-based awards |
||||||||
Weighted-average common shares used in diluted earnings per share calculations |
||||||||
Income from continuing operations: |
||||||||
Income from continuing operations |
$ | $ | ||||||
Less: net income from continuing operations attributable to noncontrolling interests |
||||||||
Income from continuing operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Basic per share |
$ | $ | ||||||
Diluted per share |
$ | $ | ||||||
Loss from discontinued operations: |
||||||||
Loss from discontinued operations, net of taxes |
$ | $ | ( |
) | ||||
Less: net income from discontinued operations attributable to noncontrolling interests |
||||||||
Loss from discontinued operations available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ( |
) | ||||
Basic per share |
$ | $ | ||||||
Diluted per share |
$ | $ | ||||||
Net income: |
||||||||
Income from continuing operations |
$ | $ | ||||||
Loss from discontinued operations, net of taxes |
( |
) | ||||||
Net income |
||||||||
Less: net income attributable to noncontrolling interests |
||||||||
Net income available to Genworth Financial, Inc.’s common stockholders |
$ | $ | ||||||
Basic per share |
$ | $ | ||||||
Diluted per share |
$ | $ | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2023 |
2022 |
||||||
Fixed maturity securities—taxable |
$ | $ | ||||||
Fixed maturity securities—non-taxable |
||||||||
Equity securities |
||||||||
Commercial mortgage loans |
||||||||
Policy loans |
||||||||
Limited partnerships |
||||||||
Other invested assets |
||||||||
Cash, cash equivalents, restricted cash and short-term investments |
||||||||
Gross investment income before expenses and fees |
||||||||
Expenses and fees |
( |
) | ( |
) | ||||
Net investment income |
$ | $ | ||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2023 |
2022 |
||||||
Realized investment gains (losses): |
||||||||
Available-for-sale |
||||||||
Realized gains |
$ | $ | ||||||
Realized losses |
( |
) | ( |
) | ||||
Net realized gains (losses) on available-for-sale |
( |
) | ( |
) | ||||
Net realized gains (losses) on equity securities sold |
||||||||
Net realized gains (losses) on limited partnerships |
||||||||
Total net realized investment gains (losses) |
( |
) | ( |
) | ||||
Net change in allowance for credit losses on available-for-sale |
( |
) | ||||||
Write-down of available-for-sale (1) |
( |
) | ||||||
Net unrealized gains (losses) on equity securities still held |
( |
) | ||||||
Net unrealized gains (losses) on limited partnerships |
||||||||
Commercial mortgage loans |
( |
) | ||||||
Derivative instruments (2) |
||||||||
Other |
( |
) | ||||||
Net investment gains (losses) |
$ | ( |
) | $ | ||||
(1) |
Represents write-down of securities deemed uncollectible or that we intend to sell or will be required to sell prior to recovery of the amortized cost basis. |
(2) |
See note 6 for additional information on the impact of derivative instruments included in net investment gains (losses). |
(Amounts in millions) |
Beginning balance |
Increase from securities without allowance in previous periods |
Increase (decrease) from securities with allowance in previous periods |
Securities sold |
Decrease due to change in intent or requirement to sell |
Write-offs |
Recoveries |
Ending balance |
||||||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||||||||||||||
U.S. corporate |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Commercial mortgage-backed |
||||||||||||||||||||||||||||||||
Total available-for-sale |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
(Amounts in millions) |
March 31, 2023 |
December 31, 2022 |
||||||
Net unrealized gains (losses) on fixed maturity securities without an allowance for credit losses (1) |
$ | ( |
) | $ | ( |
) | ||
Net unrealized gains (losses) on fixed maturity securities with an allowance for credit losses (1) |
( |
) | ||||||
Adjustments to policyholder contract balances |
||||||||
Income taxes, net |
||||||||
Net unrealized investment gains (losses) |
( |
) | ( |
) | ||||
Less: net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ( |
) | ||||
Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. |
$ | ( |
) | $ | ( |
) | ||
(1) |
Excludes foreign exchange. |
| (Amounts in millions) |
2023 |
2022 |
||||||
| Beginning balance |
$ | ( |
) | $ | ||||
| Unrealized gains (losses) arising during the period: |
||||||||
| Unrealized gains (losses) on fixed maturity securities |
( |
) | ||||||
| Adjustments to policyholder contract balances |
( |
) | ||||||
| Provision for income taxes |
( |
) | ||||||
| |
|
|
|
|||||
| Change in unrealized gains (losses) on investment securities |
( |
) | ||||||
| Reclassification adjustments to net investment (gains) losses, net of taxes of $( |
||||||||
| |
|
|
|
|||||
| Change in net unrealized investment gains (losses) |
( |
) | ||||||
| Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests |
( |
) | ||||||
| |
|
|
|
|||||
| Ending balance |
$ | ( |
) | $ | ||||
| |
|
|
|
|||||
| (Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||
| U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
| State and political subdivisions |
( |
) | ||||||||||||||||||
| Non-U.S. government |
( |
) | ||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||
| Utilities |
( |
) | ||||||||||||||||||
| Energy |
( |
) | ||||||||||||||||||
| Finance and insurance |
( |
) | ( |
) | ||||||||||||||||
| Consumer—non-cyclical |
( |
) | ||||||||||||||||||
| Technology and communications |
( |
) | ||||||||||||||||||
| Industrial |
( |
) | ||||||||||||||||||
| Capital goods |
( |
) | ||||||||||||||||||
| Consumer—cyclical |
( |
) | ( |
) | ||||||||||||||||
| Transportation |
( |
) | ||||||||||||||||||
| Other |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total U.S. corporate |
( |
) | ( |
) | ||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||
| Utilities |
( |
) | ||||||||||||||||||
| Energy |
( |
) | ||||||||||||||||||
| Finance and insurance |
( |
) | ||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ||||||||||||||||||
| Technology and communications |
( |
) | ||||||||||||||||||
| Industrial |
( |
) | ||||||||||||||||||
| Capital goods |
( |
) | ||||||||||||||||||
| Consumer—cyclical |
( |
) | ||||||||||||||||||
| Transportation |
( |
) | ||||||||||||||||||
| Other |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total non-U.S. corporate |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Residential mortgage-backed |
( |
) | ||||||||||||||||||
| Commercial mortgage-backed |
( |
) | ( |
) | ||||||||||||||||
| Other asset-backed |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total available-for-sale |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| (Amounts in millions) |
Amortized cost or cost |
Gross unrealized gains |
Gross unrealized losses |
Allowance for credit losses |
Fair value |
|||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||
| U.S. government, agencies and government-sponsored enterprises |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
| State and political subdivisions |
( |
) | ||||||||||||||||||
| Non-U.S. government |
( |
) | ||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||
| Utilities |
( |
) | ||||||||||||||||||
| Energy |
( |
) | ||||||||||||||||||
| Finance and insurance |
( |
) | ||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ||||||||||||||||||
| Technology and communications |
( |
) | ||||||||||||||||||
| Industrial |
( |
) | ||||||||||||||||||
| Capital goods |
( |
) | ||||||||||||||||||
| Consumer—cyclical |
( |
) | ||||||||||||||||||
| Transportation |
( |
) | ||||||||||||||||||
| Other |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total U.S. corporate |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||
| Utilities |
( |
) | ||||||||||||||||||
| Energy |
( |
) | ||||||||||||||||||
| Finance and insurance |
( |
) | ||||||||||||||||||
| Consumer—non-cyclical |
( |
) | ||||||||||||||||||
| Technology and communications |
( |
) | ||||||||||||||||||
| Industrial |
( |
) | ||||||||||||||||||
| Capital goods |
( |
) | ||||||||||||||||||
| Consumer—cyclical |
( |
) | ||||||||||||||||||
| Transportation |
( |
) | ||||||||||||||||||
| Other |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total non-U.S. corporate |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Residential mortgage-backed |
( |
) | ||||||||||||||||||
| Commercial mortgage-backed |
( |
) | ||||||||||||||||||
| Other asset-backed |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
| Total available-for-sale |
$ | $ | $ | ( |
) | $ | $ | |||||||||||||
| |
|
|
|
|
|
|
|
|
|
|||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
| (Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
| Description of Securities |
||||||||||||||||||||||||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
| U.S. government, agencies and government-sponsored enterprises |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| State and political subdivisions |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Non-U.S. government |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| U.S. corporate |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Non-U.S. corporate |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Residential mortgage-backed |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Commercial mortgage-backed |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Other asset-backed |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| % Below cost: |
||||||||||||||||||||||||||||||||||||
| <20% Below cost |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| 20%-50% Below cost |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Investment grade |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| Below investment grade |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
| (Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
| Description of Securities |
||||||||||||||||||||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||||||||||||||||||
| Utilities |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| Energy |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Technology and communications |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Industrial |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Capital goods |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Transportation |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Other |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Subtotal, U.S. corporate securities |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
| Utilities |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Energy |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Technology and communications |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Industrial |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Capital goods |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Transportation |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Other |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Subtotal, non-U.S. corporate securities |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for corporate securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
| (Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
| Description of Securities |
||||||||||||||||||||||||||||||||||||
| Fixed maturity securities: |
||||||||||||||||||||||||||||||||||||
| U.S. government, agencies and government-sponsored enterprises |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| State and political subdivisions |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Non-U.S. government |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| U.S. corporate |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Non-U.S. corporate |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Residential mortgage-backed |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Commercial mortgage-backed |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Other asset-backed |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| % Below cost: |
||||||||||||||||||||||||||||||||||||
| <20% Below cost |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| 20%-50% Below cost |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| >50% Below cost |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Investment grade |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| Below investment grade |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for fixed maturity securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Less than 12 months |
12 months or more |
Total |
||||||||||||||||||||||||||||||||||
| (Dollar amounts in millions) |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
Fair value |
Gross unrealized losses |
Number of securities |
|||||||||||||||||||||||||||
| Description of Securities |
||||||||||||||||||||||||||||||||||||
| U.S. corporate: |
||||||||||||||||||||||||||||||||||||
| Utilities |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| Energy |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Technology and communications |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Industrial |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Capital goods |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Transportation |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Other |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Subtotal, U.S. corporate securities |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Non-U.S. corporate: |
||||||||||||||||||||||||||||||||||||
| Utilities |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Energy |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Finance and insurance |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—non-cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Technology and communications |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Industrial |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Capital goods |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Consumer—cyclical |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Transportation |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| Other |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Subtotal, non-U.S. corporate securities |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
| Total for corporate securities in an unrealized loss position |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
$ |
$ |
( |
) |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Amortized |
||||||||
| (Amounts in millions) |
cost or cost |
Fair value |
||||||
| Due one year or less |
$ | $ | ||||||
| Due after one year through five years |
||||||||
| Due after five years through ten years |
||||||||
| Due after ten years |
||||||||
| |
|
|
|
|||||
| Subtotal |
||||||||
| Residential mortgage-backed |
||||||||
| Commercial mortgage-backed |
||||||||
| Other asset-backed |
||||||||
| |
|
|
|
|||||
| Total |
$ | $ | ||||||
| |
|
|
|
|||||
March 31, 2023 |
December 31, 2022 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Property type: |
||||||||||||||||
Retail |
$ | % | $ | % | ||||||||||||
Office |
||||||||||||||||
Industrial |
||||||||||||||||
Apartments |
||||||||||||||||
Mixed use |
||||||||||||||||
Other |
||||||||||||||||
Subtotal |
% | % | ||||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | $ | ||||||||||||||
March 31, 2023 |
December 31, 2022 |
|||||||||||||||
(Amounts in millions) |
Carrying value |
% of total |
Carrying value |
% of total |
||||||||||||
Geographic region: |
||||||||||||||||
South Atlantic |
$ | % | $ | % | ||||||||||||
Pacific |
||||||||||||||||
Mountain |
||||||||||||||||
Middle Atlantic |
||||||||||||||||
West South Central |
||||||||||||||||
East North Central |
||||||||||||||||
West North Central |
||||||||||||||||
East South Central |
||||||||||||||||
New England |
||||||||||||||||
Subtotal |
% | % | ||||||||||||||
Allowance for credit losses |
( |
) | ( |
) | ||||||||||||
Total |
$ | $ | ||||||||||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2023 |
2022 |
||||||
Allowance for credit losses: |
||||||||
Beginning balance |
$ | $ | ||||||
Provision |
( |
) | ||||||
Write-offs |
||||||||
Recoveries |
||||||||
Ending balance |
$ | $ | ||||||
(Amounts in millions) |
2023 |
2022 |
2021 |
2020 |
2019 |
2018 and prior |
Total |
|||||||||||||||||||||
Debt-to-value: |
||||||||||||||||||||||||||||
0% - 50% |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
51% - 60% |
||||||||||||||||||||||||||||
61% - 75% |
||||||||||||||||||||||||||||
76% - 100% |
||||||||||||||||||||||||||||
Greater than 100% |
||||||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Debt service coverage ratio: |
||||||||||||||||||||||||||||
Less than 1.00 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
1.00 - 1.25 |
||||||||||||||||||||||||||||
1.26 - 1.50 |
||||||||||||||||||||||||||||
1.51 - 2.00 |
||||||||||||||||||||||||||||
Greater than 2.00 |
||||||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
March 31, 2023 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
December 31, 2022 |
||||||||||||||||||||||||
(Amounts in millions) |
0% - 50% |
51% - 60% |
61% - 75% |
76% - 100% |
Greater than 100% |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt service coverage ratio |
||||||||||||||||||||||||
March 31, 2023 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
December 31, 2022 |
||||||||||||||||||||||||
(Amounts in millions) |
Less than 1.00 |
1.00 - 1.25 |
1.26 - 1.50 |
1.51 - 2.00 |
Greater than 2.00 |
Total |
||||||||||||||||||
Property type: |
||||||||||||||||||||||||
Retail |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
Office |
||||||||||||||||||||||||
Industrial |
||||||||||||||||||||||||
Apartments |
||||||||||||||||||||||||
Mixed use |
||||||||||||||||||||||||
Other |
||||||||||||||||||||||||
Total amortized cost |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
% of total |
% | % | % | % | % | % | ||||||||||||||||||
Weighted-average debt-to-value |
% | % | % | % | % | % | ||||||||||||||||||
Derivative assets |
Derivative liabilities |
|||||||||||||||||||||||
Fair value |
Fair value |
|||||||||||||||||||||||
(Amounts in millions) |
Balance sheet classification |
March 31, 2023 |
December 31, 2022 |
Balance sheet classification |
March 31, 2023 |
December 31, 2022 |
||||||||||||||||||
Derivatives designated as hedges |
||||||||||||||||||||||||
Cash flow hedges: |
||||||||||||||||||||||||
Interest rate swaps |
Other invested assets |
$ |
$ |
Other liabilities |
$ |
$ |
||||||||||||||||||
Foreign currency swaps |
Other invested assets |
Other liabilities |
||||||||||||||||||||||
Total cash flow hedges |
||||||||||||||||||||||||
Total derivatives designated as hedges |
||||||||||||||||||||||||
Derivatives not designated as hedges |
||||||||||||||||||||||||
Equity index options |
Other invested assets |
Other liabilities |
||||||||||||||||||||||
Financial futures |
Other invested assets |
Other liabilities |
||||||||||||||||||||||
Fixed index annuity embedded derivatives |
Other assets |
Policyholder account balances (1) |
||||||||||||||||||||||
Indexed universal life embedded derivatives |
Reinsurance recoverable |
Policyholder account balances (2) |
||||||||||||||||||||||
Total derivatives not designated as hedges |
||||||||||||||||||||||||
Total derivatives |
$ |
$ |
$ |
$ |
||||||||||||||||||||
(1) |
Represents the embedded derivatives associated with our fixed index annuity liabilities. |
(2) |
Represents the embedded derivatives associated with our indexed universal life liabilities. |
| (Notional in millions) |
Measurement |
December 31, 2022 |
Additions |
Maturities/ terminations |
March 31, 2023 |
|||||||||||||||
| Derivatives designated as hedges |
||||||||||||||||||||
| Cash flow hedges: |
||||||||||||||||||||
| Interest rate swaps |
Notional | $ | $ | $ | ( |
) | $ | |||||||||||||
| Foreign currency swaps |
Notional | ( |
) | |||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||||||
| Total cash flow hedges |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||||||
| Total derivatives designated as hedges |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||||||
| Derivatives not designated as hedges |
||||||||||||||||||||
| Equity index options |
Notional | ( |
) | |||||||||||||||||
| Financial futures |
Notional | ( |
) | |||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||||||
| Total derivatives not designated as hedges |
( |
) | ||||||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||||||
| Total derivatives |
$ | $ | $ | ( |
) | $ | ||||||||||||||
| |
|
|
|
|
|
|
|
|||||||||||||
| (Number of policies) |
Measurement |
December 31, 2022 |
Additions |
Maturities/ terminations |
March 31, 2023 |
|||||||||||||||
| Derivatives not designated as hedges |
||||||||||||||||||||
| Fixed index annuity embedded derivatives |
Policies |
( |
) |
|||||||||||||||||
| Indexed universal life embedded derivatives |
Policies |
( |
) |
|||||||||||||||||
| (Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income from OCI |
Classification of gain (loss) reclassified into net income |
Gain (loss) recognized in net income |
Classification of gain (loss) recognized in net income |
|||||||||||||||
| Interest rate swaps hedging assets |
$ | $ | |
Net investment income |
|
$ | |
Net investment gains (losses) |
| |||||||||||
| Interest rate swaps hedging assets |
|
Net investment gains (losses) |
|
|
Net investment gains (losses) |
| ||||||||||||||
| Interest rate swaps hedging liabilities |
( |
) | |
Interest expense |
|
|
Net investment gains (losses) |
| ||||||||||||
| Interest rate swaps hedging liabilities |
|
Net investment gains (losses) |
|
|
Net investment gains (losses) |
| ||||||||||||||
| Foreign currency swaps |
( |
) | |
Net investment income |
|
|
Net investment gains (losses) |
| ||||||||||||
| Foreign currency swaps |
|
Net investment gains (losses) |
|
|
Net investment gains (losses) |
| ||||||||||||||
| |
|
|
|
|
|
|
|
|
| |||||||||||
| Total |
$ | $ | |
|
$ | |
| |||||||||||||
| |
|
|
|
|
|
|
|
|
| |||||||||||
| (Amounts in millions) |
Gain (loss) recognized in OCI |
Gain (loss) reclassified into net income from OCI |
Classification of gain (loss) reclassified into net income |
Gain (loss) recognized in net income |
Classification of gain (loss) recognized in net income |
|||||||||||||||
| Interest rate swaps hedging assets |
$ |
( |
) |
$ |
Net investment income |
$ |
Net investment gains (losses) |
|||||||||||||
| Interest rate swaps hedging assets |
Net investment gains (losses) |
Net investment gains (losses) |
||||||||||||||||||
| Interest rate swaps hedging liabilities |
( |
) |
Interest expense |
Net investment gains (losses) |
||||||||||||||||
| Foreign currency swaps |
( |
) |
Net investment income |
Net investment gains (losses) |
||||||||||||||||
| |
|
|
|
|
|
|||||||||||||||
| Total |
$ |
( |
) |
$ |
$ |
|||||||||||||||
| |
|
|
|
|
|
|||||||||||||||
Three months ended March 31, |
||||||||
(Amounts in millions) |
2023 |
2022 |
||||||
Derivatives qualifying as effective accounting hedges as of January 1 |
$ | $ | ||||||
Current period increases (decreases) in fair value, net of deferred taxes of $( |
( |
) | ||||||
Reclassification to net (income), net of deferred taxes of $ |
( |
) | ( |
) | ||||
Derivatives qualifying as effective accounting hedges as of March 31 |
$ | $ | ||||||
Three months ended March 31, |
Classification of gain (loss) recognized in net income |
|||||||||||
(Amounts in millions) |
2023 |
2022 |
||||||||||
Equity index options |
$ |
$ |
( |
) |
Net investment gains (losses) |
|||||||
Financial futures |
( |
) |
( |
) |
Changes in fair value of market risk benefits and associated hedges |
|||||||
Fixed index annuity embedded derivatives |
( |
) |
Net investment gains (losses) |
|||||||||
Indexed universal life embedded derivatives |
Net investment gains (losses) |
|||||||||||
Total derivatives not designated as hedges |
$ |
$ |
( |
) |
||||||||
March 31, 2023 |
December 31, 2022 |
|||||||||||||||||||||||
(Amounts in millions) |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
Derivative assets (1) |
Derivative liabilities (1) |
Net derivatives |
||||||||||||||||||
Amounts presented in the balance sheet: |
||||||||||||||||||||||||
Gross amounts recognized |
$ | $ | $ | ( |
) | $ | $ | $ | ( |
) | ||||||||||||||
Gross amounts offset in the balance sheet |
||||||||||||||||||||||||
Net amounts presented in the balance sheet |
( |
) | ( |
) | ||||||||||||||||||||
Gross amounts not offset in the balance sheet: |
||||||||||||||||||||||||
Financial instruments (2) |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral received |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Collateral pledged |
( |
) | ( |
) | ||||||||||||||||||||
Over collateralization |
( |
) | ( |
) | ||||||||||||||||||||
Net amount |
$ | $ | $ | $ | $ | $ | ||||||||||||||||||
(1) |
Does not include amounts related to embedded derivatives as of March 31, 2023 and December 31, 2022. |
(2) |
Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. |
| • | Third-party pricing services: |
(Amounts in millions) |
Fair value |
Primary methodologies |
Significant inputs | |||||
U.S. government, agencies and government-sponsored enterprises |
$ |
|||||||
State and political subdivisions |
$ |
|||||||
Non-U.S. government |
$ |
|||||||
U.S. corporate |
$ |
|||||||
Non-U.S. corporate |
$ |
|||||||
Residential mortgage-backed |
$ |
|||||||
Commercial mortgage-backed |
$ |
|||||||
Other asset-backed |
$ |
|||||||
| • | Internal models: non-U.S. corporate securities are valued using internal models. The fair value of these fixed maturity securities was $ |
| • | Broker quotes: non-U.S. corporate, residential mortgage-backed, commercial mortgage-backed and other asset-backed securities are valued using broker quotes. Broker quotes are obtained from third-party providers that have current market knowledge to provide a reasonable price for securities not routinely priced by pricing services. Brokers utilized for valuation of assets are reviewed annually. The fair value of our Level 3 fixed maturity securities priced by broker quotes was $ |
| • | Internal models: non-U.S. corporate, residential mortgage-backed and other asset-backed securities are valued using internal models. The primary inputs to the valuation of the bond population include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, duration, call provisions, issuer rating, benchmark yields and credit spreads. Certain private fixed maturity securities are valued using an internal model using market observable inputs such as the interest rate yield curve, as well as published credit spreads for similar securities, which includes significant unobservable inputs. Additionally, we may apply certain price caps and liquidity premiums in the valuation of private fixed maturity securities. Price caps are established using inputs from market participants. For structured securities, the primary inputs to the valuation include quoted prices for identical assets, or similar assets in markets that are not active, contractual cash flows, weighted-average coupon, weighted-average maturity, issuer rating, structure of the security, expected prepayment speeds and volumes,collateral type, current and forecasted loss severity, average delinquency rates, vintage of the loans, geographic region, debt service coverage ratios, payment priority with the tranche, benchmark yields and credit spreads. The fair value of our Level 3 fixed maturity securities priced using internal models was $ |
March 31, 2023 |
||||||||||||||||||||
(Amounts in millions) |
Total |
Level 1 |
Level 2 |
Level 3 |
NAV (1) |
|||||||||||||||
Assets |
||||||||||||||||||||
Investments: |
||||||||||||||||||||
Fixed maturity securities: |
||||||||||||||||||||
U.S. government, agencies and government-sponsored enterprises |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||
State and political subdivisions |
||||||||||||||||||||
Non-U.S. government |
||||||||||||||||||||
U.S. corporate: |
||||||||||||||||||||
Utilities |
||||||||||||||||||||
Energy |
||||||||||||||||||||
Finance and insurance |
||||||||||||||||||||
Consumer—non-cyclical |
||||||||||||||||||||
Technology and communications |
||||||||||||||||||||
Industrial |
||||||||||||||||||||
Capital goods |
||||||||||||||||||||